Do analysts prefer ONCO or MEHA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Onconetix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend MEHA or ATXI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Avenue Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is MEHA or ATXI more profitable?

Functional Brands' return on equity of 0.00% beat Avenue Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Functional Brands N/A N/A N/A Avenue Therapeutics N/A -471.57% -296.50%

Do analysts prefer NMTR or MEHA?

Given 9 Meters Biopharma's higher probable upside, analysts plainly believe 9 Meters Biopharma is more favorable than Functional Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 9 Meters Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NMTR or MEHA more profitable?

Functional Brands' return on equity of 0.00% beat 9 Meters Biopharma's return on equity. Company Net Margins Return on Equity Return on Assets 9 Meters Biopharma N/A -584.97% -159.45% Functional Brands N/A N/A N/A

Do analysts rate MEHA or CARM?

Carisma Therapeutics has a consensus target price of $1.00, indicating a potential upside of 12,245.68%. Given Carisma Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Carisma Therapeutics is more favorable than Functional Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Carisma Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Is MEHA or CARM more profitable?

Functional Brands has a net margin of 0.00% compared to Carisma Therapeutics' net margin of -254.28%. Company Net Margins Return on Equity Return on Assets Functional Brands N/A N/A N/A Carisma Therapeutics -254.28% N/A -192.17%

Functional Brands (MEHA) Competitors

$0.0051 0.00 (-7.27%)

As of 03:50 PM Eastern

Compare

MEHA vs. ONCO, ATXI, SBFM, NMTR, and CARM

Should you buy Functional Brands stock or one of its competitors? MarketBeat compares Functional Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Functional Brands include Onconetix (ONCO), Avenue Therapeutics (ATXI), Sunshine Biopharma (SBFM), 9 Meters Biopharma (NMTR), and Carisma Therapeutics (CARM). These companies are all part of the "pharmaceutical products" industry.

How does Functional Brands compare to Onconetix?

Onconetix (NASDAQ:ONCO) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Functional Brands has a net margin of 0.00% compared to Onconetix's net margin of -1,316.28%. Functional Brands' return on equity of 0.00% beat Onconetix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Onconetix	-1,316.28%	-101.08%	-47.34%
Functional Brands	N/A	N/A	N/A

23.9% of Onconetix shares are owned by institutional investors. 0.3% of Onconetix shares are owned by company insiders. Comparatively, 4.3% of Functional Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Onconetix had 4 more articles in the media than Functional Brands. MarketBeat recorded 4 mentions for Onconetix and 0 mentions for Functional Brands. Onconetix's average media sentiment score of 0.29 beat Functional Brands' score of 0.00 indicating that Onconetix is being referred to more favorably in the media.

Company	Overall Sentiment
Onconetix	Neutral
Functional Brands	Neutral

Functional Brands has higher revenue and earnings than Onconetix. Functional Brands is trading at a lower price-to-earnings ratio than Onconetix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Onconetix	$810K	1.38	-$14.03M	$11.40	0.09
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Onconetix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Onconetix and Functional Brands tied by winning 6 of the 12 factors compared between the two stocks.

How does Functional Brands compare to Avenue Therapeutics?

Functional Brands (NASDAQ:MEHA) and Avenue Therapeutics (NASDAQ:ATXI) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Functional Brands has higher revenue and earnings than Avenue Therapeutics. Avenue Therapeutics is trading at a lower price-to-earnings ratio than Functional Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A
Avenue Therapeutics	N/A	N/A	-$10.38M	-$0.53	N/A

Functional Brands' return on equity of 0.00% beat Avenue Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Avenue Therapeutics	N/A	-471.57%	-296.50%

17.3% of Avenue Therapeutics shares are held by institutional investors. 4.3% of Functional Brands shares are held by company insiders. Comparatively, 8.6% of Avenue Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Functional Brands' average media sentiment score of 0.00 equaled Avenue Therapeutics'average media sentiment score.

Company	Overall Sentiment
Functional Brands	Neutral
Avenue Therapeutics	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Avenue Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Functional Brands beats Avenue Therapeutics on 6 of the 9 factors compared between the two stocks.

How does Functional Brands compare to Sunshine Biopharma?

Sunshine Biopharma (NASDAQ:SBFM) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Functional Brands has lower revenue, but higher earnings than Sunshine Biopharma. Sunshine Biopharma is trading at a lower price-to-earnings ratio than Functional Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sunshine Biopharma	$36.31M	0.03	-$5.97M	-$12.90	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Sunshine Biopharma currently has a consensus target price of $70.00, indicating a potential upside of 3,171.03%. Given Sunshine Biopharma's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sunshine Biopharma is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sunshine Biopharma	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -18.45%. Functional Brands' return on equity of 0.00% beat Sunshine Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sunshine Biopharma	-18.45%	-27.75%	-21.57%
Functional Brands	N/A	N/A	N/A

42.0% of Sunshine Biopharma shares are held by institutional investors. 0.5% of Sunshine Biopharma shares are held by insiders. Comparatively, 4.3% of Functional Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Sunshine Biopharma had 1 more articles in the media than Functional Brands. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Functional Brands. Sunshine Biopharma's average media sentiment score of 0.00 equaled Functional Brands'average media sentiment score.

Company	Overall Sentiment
Sunshine Biopharma	Neutral
Functional Brands	Neutral

Summary

Functional Brands beats Sunshine Biopharma on 8 of the 14 factors compared between the two stocks.

How does Functional Brands compare to 9 Meters Biopharma?

9 Meters Biopharma (NASDAQ:NMTR) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

In the previous week, 9 Meters Biopharma's average media sentiment score of 0.00 equaled Functional Brands'average media sentiment score.

Company	Overall Sentiment
9 Meters Biopharma	Neutral
Functional Brands	Neutral

Functional Brands' return on equity of 0.00% beat 9 Meters Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
9 Meters Biopharma	N/A	-584.97%	-159.45%
Functional Brands	N/A	N/A	N/A

Given 9 Meters Biopharma's higher probable upside, analysts plainly believe 9 Meters Biopharma is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
9 Meters Biopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.3% of 9 Meters Biopharma shares are held by institutional investors. 2.4% of 9 Meters Biopharma shares are held by insiders. Comparatively, 4.3% of Functional Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Functional Brands has higher revenue and earnings than 9 Meters Biopharma. Functional Brands is trading at a lower price-to-earnings ratio than 9 Meters Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
9 Meters Biopharma	N/A	N/A	-$43.77M	-$3.46	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Summary

Functional Brands beats 9 Meters Biopharma on 7 of the 10 factors compared between the two stocks.

How does Functional Brands compare to Carisma Therapeutics?

Functional Brands (NASDAQ:MEHA) and Carisma Therapeutics (NASDAQ:CARM) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

Carisma Therapeutics has a consensus target price of $1.00, indicating a potential upside of 12,245.68%. Given Carisma Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Carisma Therapeutics is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Carisma Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

44.3% of Carisma Therapeutics shares are owned by institutional investors. 4.3% of Functional Brands shares are owned by insiders. Comparatively, 6.9% of Carisma Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Functional Brands' average media sentiment score of 0.00 equaled Carisma Therapeutics'average media sentiment score.

Company	Overall Sentiment
Functional Brands	Neutral
Carisma Therapeutics	Neutral

Functional Brands has a net margin of 0.00% compared to Carisma Therapeutics' net margin of -254.28%.

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Carisma Therapeutics	-254.28%	N/A	-192.17%

Functional Brands has higher earnings, but lower revenue than Carisma Therapeutics. Functional Brands is trading at a lower price-to-earnings ratio than Carisma Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A
Carisma Therapeutics	$10.77M	0.03	-$60.48M	$0.73	0.01

Summary

Carisma Therapeutics beats Functional Brands on 9 of the 13 factors compared between the two stocks.

Get Functional Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEHA vs. The Competition

Export

Metric	Functional Brands	Medicinal Chemicals Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$218K	$1.78B	$4.34B	$12.21B
Dividend Yield	N/A	N/A	11.44%	5.89%
P/E Ratio	-0.02	N/A	22.03	24.03
Price / Sales	0.03	0.72	153.72	117.77
Price / Cash	0.27	0.27	39.06	53.76
Price / Book	0.06	374.53	14.75	6.32
Net Income	$760K	-$1.41M	$115.37M	$337.22M
7 Day Performance	N/A	-25.56%	-1.61%	-1.20%
1 Month Performance	N/A	-70.97%	-2.24%	0.40%
1 Year Performance	N/A	-65.53%	11.93%	29.26%

Functional Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEHA Functional Brands	0.1281 of 5 stars	$0.01 -7.3%	N/A	N/A	$218K	$6.67M	N/A	33	Short Interest Decrease Gap Up
ONCO Onconetix	2.1588 of 5 stars	$0.94 flat	N/A	-99.5%	$1.08M	$735.20K	0.08	12	News Coverage Short Interest Decrease
ATXI Avenue Therapeutics	N/A	$0.33 flat	N/A	+45.5%	$1.07M	N/A	0.02	4
SBFM Sunshine Biopharma	1.7779 of 5 stars	$2.13 flat	$70.00 +3,186.4%	-86.3%	$1.07M	$36.31M	N/A	3	News Coverage Short Interest Decrease Gap Down
NMTR 9 Meters Biopharma	N/A	N/A	N/A	N/A	$1.04M	N/A	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEHA) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Functional Brands (MEHA) Competitors

MEHA vs. ONCO, ATXI, SBFM, NMTR, and CARM

How does Functional Brands compare to Onconetix?

Summary

How does Functional Brands compare to Avenue Therapeutics?

Summary

How does Functional Brands compare to Sunshine Biopharma?

Summary

How does Functional Brands compare to 9 Meters Biopharma?

Summary

How does Functional Brands compare to Carisma Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Functional Brands (MEHA) Competitors

MEHA vs. ONCO, ATXI, SBFM, NMTR, and CARM

How does Functional Brands compare to Onconetix?

Is ONCO or MEHA more profitable?

Do insiders and institutionals have more ownership in ONCO or MEHA?

Does the media favor ONCO or MEHA?

Which has better valuation and earnings, ONCO or MEHA?

Do analysts prefer ONCO or MEHA?

Summary

How does Functional Brands compare to Avenue Therapeutics?

Which has better earnings & valuation, MEHA or ATXI?

Is MEHA or ATXI more profitable?

Do insiders and institutionals have more ownership in MEHA or ATXI?

Does the media favor MEHA or ATXI?

Do analysts recommend MEHA or ATXI?

Summary

How does Functional Brands compare to Sunshine Biopharma?

Which has preferable valuation & earnings, SBFM or MEHA?

Do analysts recommend SBFM or MEHA?

Is SBFM or MEHA more profitable?

Do insiders & institutionals have more ownership in SBFM or MEHA?

Does the media favor SBFM or MEHA?

Summary

How does Functional Brands compare to 9 Meters Biopharma?

Does the media prefer NMTR or MEHA?

Is NMTR or MEHA more profitable?

Do analysts prefer NMTR or MEHA?

Do insiders and institutionals believe in NMTR or MEHA?

Which has stronger earnings & valuation, NMTR or MEHA?

Summary

How does Functional Brands compare to Carisma Therapeutics?

Do analysts rate MEHA or CARM?

Do institutionals & insiders have more ownership in MEHA or CARM?

Does the media prefer MEHA or CARM?

Is MEHA or CARM more profitable?

Which has stronger earnings and valuation, MEHA or CARM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools